Načítá se...
Novel oral anticoagulants for acute coronary syndrome
Acute coronary syndrome (ACS) is a cardiovascular condition with a multifactorial pathophysiology that includes atherosclerotic plaques, platelet activation and thrombin production, among others. Thrombin production and the prothrombotic state of ACS patients have provided a role for anticoagulants...
Uloženo v:
| Vydáno v: | Ther Adv Cardiovasc Dis |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5933556/ https://ncbi.nlm.nih.gov/pubmed/27765885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753944716671484 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|